Validation, in a Pediatric Population, of a French Translation of the MEPS/MEPI Score (MEPS-Fr)

June 10, 2026 updated by: Centre Hospitalier Universitaire, Amiens
The MEPI (Modified Elbow Performance Index) or MEPS (Modified Elbow Performance Score) is a multidimensional assessment scale for elbow pain and function. This score is widely used in scientific literature, particularly for post-traumatic and post-operative evaluation, including in many French-language studies. However, no French translation of this score has undergone quality criteria verification and validation in a pediatric population.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Pre-test volunteer group:
  • Patients aged 4 to 17 years followed in the department without an elbow injury
  • Follow-up schedule compatible with the study protocol
  • No objection from a parent or legal guardian, with the child's consent if age permits
  • Test volunteer group:
  • Patients aged 4 to 17 years followed in the department with a diagnosis of an elbow injury
  • Follow-up schedule compatible with the study protocol
  • No objection from a parent or legal guardian, with the child's consent

Exclusion Criteria:

  • Pre-test volunteer group:
  • Language barrier, lack of understanding of French
  • Refusal to participate
  • Confounding factor impairing function
  • Opposition of parent or legal guardian and/or refusal of child if age permits
  • Test volunteer group:
  • Language barrier, lack of understanding of French
  • Refusal to participate
  • Confounding factor impairing function
  • Opposition of parent or legal guardian and/or refusal of child if age permits

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: pre-test
patients without elbow injury
Device: MEPS-Fr version
The MEPS-Fr version will be tested on 120 patients treated either orthopedically or surgically for an elbow injury
Experimental: validation test
patients treated either orthopedically or surgically for an elbow injury.
Device: MEPS-Fr version
The MEPS-Fr version will be tested on 120 patients treated either orthopedically or surgically for an elbow injury

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MEPS-FR score
Time Frame: day 0
Mayo Elbow Performance Score (MEPS)
day 0
MEPS-FR score
Time Frame: 6 weeks
Mayo Elbow Performance Score (MEPS)
6 weeks
MEPS-FR score
Time Frame: 12 weeks
Mayo Elbow Performance Score (MEPS)
12 weeks
PREE Score
Time Frame: day 0
The Patient-Rated Elbow Evaluation is PREE
day 0
PREE Score
Time Frame: 6 weeks
The Patient-Rated Elbow Evaluation is PREE
6 weeks
PREE Score
Time Frame: 12 weeks
The Patient-Rated Elbow Evaluation is PREE
12 weeks
quick DASH Score
Time Frame: day 0
DASH is Disabilities of the Arm, Shoulder and Hand
day 0
quick DASH Score
Time Frame: 6 weeks
DASH is Disabilities of the Arm, Shoulder and Hand
6 weeks
quick DASH Score
Time Frame: 12 weeks
DASH is Disabilities of the Arm, Shoulder and Hand
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire, Amiens

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 13, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

July 1, 2028

Study Registration Dates

First Submitted

May 28, 2026

First Submitted That Met QC Criteria

May 28, 2026

First Posted (Actual)

June 3, 2026

Study Record Updates

Last Update Posted (Actual)

June 12, 2026

Last Update Submitted That Met QC Criteria

June 10, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • PI2025_843_0157

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe